E-Paper
India's Ranbaxy gets US FDA nod for ramipril
Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules.
Updated on: Mar 9, 2009, 10:15:30 IST
Share via
Copy link
Indian drug maker Ranbaxy Laboratories Ltd said on Monday it had received approval from the US Food and Drug Administration to manufacture and market ramipril capsules.
Ramipril is used in the treatment of cardiovalscular diseases.
Stay updated with the latest Business News on Petrol Price, Gold Rate, Silver Rates, Diesel Prices along with Income Tax Calculator
